MedPath
NMPA Approval

Lacosamide Injection

国药准字H20243016

January 9, 2024

Drug Information

拉考沙胺注射液

注射剂

20ml:0.2g

化学药品

January 9, 2024

Company Information

Applicant Company

成都海峡两岸科技产业开发园柳台大道B段

Manufacturing Company

成都海峡两岸科技产业开发园柳台大道B段

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

拉考沙胺注射液 - NMPA 批准文号 | MedPath